Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kerstin Ammon"'
Autor:
Arnt V. Kristen, Falk-Udo Sack, Thomas J. Dengler, Susanne Müller, S. Celik, Kerstin Ammon, Mathias H. Konstandin, Andreas O. Doesch, Hugo A. Katus, Lutz Frankenstein
Publikováno v:
Transplant International. 23:382-389
Chronic Toxoplasma gondii infection is known to trigger potentially adverse immunoregulatory changes, but limited data exist on long-term implications for heart transplant (HTX) recipients. We evaluated the risk of all cause mortality regarding T. go
Autor:
Stefan E. Hardt, Hugo A. Katus, S. Celik, Mathias H. Konstandin, Thomas J. Dengler, Arnt V. Kristen, Kerstin Ammon, Andreas O. Doesch, Sebastian J. Buss, Falk-Udo Sack, Lutz Frankenstein
Publikováno v:
Transplantation. 88:835-841
BACKGROUND Graft denervation in heart transplant recipients causes sinus tachycardia, occasionally requiring pharmacologic heart rate reduction. Currently, no 12-month data regarding effects of the novel I(f) channel antagonist ivabradine on heart ra
Autor:
S. Celik, Kerstin Ammon, Hugo A. Katus, Christian Erbel, Achim Koch, Thomas J. Dengler, Andreas O. Doesch, Erwin Blessing
Publikováno v:
Transplantation. 86:245-250
BACKGROUND Hyperlipidemia is an important complication after organ transplantation and may contribute to the development of posttransplant-accelerated coronary artery disease. Immunosuppressive therapy, especially mammalian target of rapamycin inhibi
Autor:
Kerstin Ammon, Hugo A. Katus, Achim Koch, Guido H. Wabnitz, Christian A. Gleissner, Mathias H. Konstandin, Erwin Blessing, Thomas J. Dengler, Andreas O. Doesch, Andrew Remppis
Publikováno v:
Clinical Transplantation. 22:639-644
We investigated tolerability and efficacy of ezetimibe treatment (10 mg/d) in 25 heart allograft recipients already on stable statin therapy. Total cholesterol (TC), low-density cholesterol (LDL-C), high-density cholesterol (HDL-C), triglycerides (TG
Autor:
Hugo A. Katus, Arnt V. Kristen, M. Konstandin, Kerstin Ammon, Thomas J. Dengler, Philipp A. Schnabel, Falk-Udo Sack, Andreas O. Doesch, S. Celik
Publikováno v:
Transplantation proceedings. 43(5)
Calcineurin inhibitor (CNI)-free immunosuppression is used increasingly after heart transplantation to avoid CNI toxicity, but in the absence of a randomized trial, concerns remain over an increased rejection risk.We studied the incidence of graft re
Autor:
Kerstin Ammon, Andreas Dösch, Hugo A. Katus, Thomas J. Dengler, Christian Erbel, Achim Koch, Falk-Udo Sack, Arnt V. Kristen, S. Celik, Matthias Karck
Publikováno v:
Transplantation. 87(7)
Background. This study evaluates the objective rate of return to work after heart transplantation (HTX) in comparison with the patients' subjective rating of their work ability and identifies predictors for return to work in a German heart transplant
Autor:
Mathias H, Konstandin, Erwin, Blessing, Andreas, Doesch, Kerstin, Ammon, Achim, Koch, Guido H, Wabnitz, Christian A, Gleissner, Andrew, Remppis, Hugo A, Katus, Thomas J, Dengler
Publikováno v:
Clinical transplantation. 22(5)
We investigated tolerability and efficacy of ezetimibe treatment (10 mg/d) in 25 heart allograft recipients already on stable statin therapy. Total cholesterol (TC), low-density cholesterol (LDL-C), high-density cholesterol (HDL-C), triglycerides (TG
Autor:
Hugo A. Katus, Andreas O. Doesch, Kerstin Ammon, S. Celik, Thomas J. Dengler, Lutz Frankenstein, M. Konstandin, B. Sebastian, Falk-Udo Sack
Publikováno v:
The Journal of Heart and Lung Transplantation. 28:S227-S228